GLP1R and type 2 diabetes mellitus: Indeed, the first glucagon-like peptide 1 (GLP-1)/glucagon coagonist (cotadutide) improved glycemic control, weight loss, and even improved metabolic profiles in patients who were overweight or obese and had T2D in a Phase 2b clinical trial (37).